Spatiotemporal immune landscape and long-term immune memory in POLE-mutant endometrial cancer at the single-cell level
Brummel K. et al, (2025), Cancer Immunology Research
Replication-associated mechanisms contribute to an increased CpG > TpG mutation burden in mismatch repair-deficient cancers
Ward JC. et al, (2025), Genome Medicine, 17
Activin A affects colorectal cancer progression and immunomodulation in a stage dependent manner.
Wiley MB. et al, (2025), Scientific reports, 15
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study.
Eerkens AL. et al, (2024), Nature communications, 15
Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancer.
Nowak M. et al, (2024), Cell reports. Medicine, 5
The genomic landscape of 2,023 colorectal cancers.
Cornish AJ. et al, (2024), Nature, 633, 127 - 136
Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts.
Taieb J. et al, (2024), European journal of cancer (Oxford, England : 1990), 206
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies
Domingo E. et al, (2024), Journal of Clinical Oncology, 42, 2207 - 2218
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
Pennel KAF. et al, (2024), Journal of experimental & clinical cancer research : CR, 43
Genetic and immune landscape evolution in MMR-deficient colorectal cancer.
Challoner BR. et al, (2024), The Journal of pathology, 262, 226 - 239
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
Frei AL. et al, (2024), The Lancet. Oncology, 25, 198 - 211
Patterns of cytotoxic T-cell densities in immunogenic endometrial cancers reveal a potential mechanism for differences in immunotherapy efficacy.
Ryan N. et al, (2024), BMJ oncology, 3
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets.
Frei AL. et al, (2023), The journal of pathology. Clinical research, 9, 449 - 463
Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis
Brown M. et al, (2023), EMBO Molecular Medicine, 15
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study.
Wagner SJ. et al, (2023), Cancer cell, 41, 1650 - 1661.e4
More than just a hangover – alcohol and carcinogenesis in Lynch syndrome
Church DN., (2023), Disease Models & Mechanisms, 16
A novel genetic marker of fluoropyrimidine-induced cardiovascular toxicity.
Palles C. et al, (2023), JOURNAL OF CLINICAL ONCOLOGY, 41
Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program.
RAINBO Research Consortium None., (2023), International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 33, 109 - 117
The English National Lynch Syndrome transformation project: an NHS Genomic Medicine Service Alliance (GMSA) programme.
Monahan KJ. et al, (2023), BMJ oncology, 2